This work provides a molecular perspective on the potential mechanisms of action of the liraglutide and pramlintide on cognition and insulin sensitivity in an HFD/STZ-induced T2DM male rat model (see Fig. 10 for the pathophysiology of CD in T2D). The gene discussed is INS; the disease is type 2 diabetes mellitus.